Short answer
Varex Imaging Corp (VREX) filed an 8-K current report with the SEC on October 22, 2026 reporting Item 8.01 (Other Events). Merger litigation expands: two complaints and 13 demand letters allege proxy disclosure deficiencies, creating delay and transaction-cost risk.
Varex Imaging Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Merger litigation expands: two complaints and 13 demand letters allege proxy disclosure deficiencies, creating delay and transaction-cost risk
- Supplemental disclosures do not change $18.90-per-share cash consideration or October 28, 2026 shareholder meeting
- Regulatory timing remains critical: HSR waiting period through November 19, 2026 and UK NSIA review through November 18, 2026
- Board maintains unanimous recommendation for merger approval despite potential additional lawsuits or amended complaints
- Valuation support is mixed: Evercore DCF range $15.00 to $21.50 per share versus $18.90 merger consideration; selected transactions ranged $13.25 to $35.75
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Varex Imaging Corp 8-K filings
Get the next VREX 8-K as it lands
Follow VREX for push alerts, or ask the research agent what this filing means.